Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
How Low Can You Go? MedImpact Offers Adalimumab At 95% Discount To Humira In US
Partners With Teva To Sell Unbranded Version Of Alvotech Biosimilar
Feb 20 2026
•
By
Dave Wallace
MedImpact is offering a Humira biosimilar at just 5% of the brand cost
(Shutterstock)
More from Biosimilars
More from Products